Slate Path Capital LP - Q4 2015 holdings

$924 Million is the total value of Slate Path Capital LP's 14 reported holdings in Q4 2015. The portfolio turnover from Q3 2015 to Q4 2015 was 81.8% .

 Value Shares↓ Weighting
PYPL BuyPAYPAL HLDGS INC$171,045,000
+1124.5%
4,725,000
+950.0%
18.51%
+1055.2%
CHTR SellCHARTER COMMUNICATIONS INC Dcl a new$126,339,000
-3.1%
690,000
-7.0%
13.67%
-8.6%
TSO SellTESORO CORP$104,843,000
-52.3%
995,000
-56.0%
11.34%
-55.0%
PODD  INSULET CORP$102,843,000
+45.9%
2,720,0000.0%11.13%
+37.7%
GDX SellMARKET VECTORS ETF TRgold miner etf$85,613,000
-9.3%
6,240,000
-9.2%
9.26%
-14.4%
TRIP NewTRIPADVISOR INC$85,444,0001,002,273
+100.0%
9.24%
ALNY BuyALNYLAM PHARMACEUTICALS INC$68,252,000
+42.7%
725,000
+21.8%
7.38%
+34.7%
Z BuyZILLOW GROUP INCcl c cap stk$56,000,000
+100.4%
2,385,000
+130.4%
6.06%
+89.0%
TWC SellTIME WARNER CABLE INC$34,334,000
-18.5%
185,000
-21.3%
3.72%
-23.1%
MDCO NewMEDICINES CO$21,284,000570,000
+100.0%
2.30%
OKE NewONEOK INC NEW$19,851,000805,000
+100.0%
2.15%
WMB NewWILLIAMS COS INC DEL$16,962,000660,000
+100.0%
1.84%
CPGX NewCOLUMBIA PIPELINE GROUP INC$16,100,000805,000
+100.0%
1.74%
KMI NewKINDER MORGAN INC DEL$15,368,0001,030,000
+100.0%
1.66%
IPXL ExitIMPAX LABORATORIES INC$0-735,000
-100.0%
-2.97%
YOKU ExitYOUKU TUDOU INCsponsored adr$0-3,690,000
-100.0%
-7.46%
SPY ExitSPDR S&P 500 ETF TRput$0-700,000
-100.0%
-15.38%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2016-02-16
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
CHARTER COMMUNICATIONS INC N30Q3 202315.2%
ALNYLAM PHARMACEUTICALS INC30Q3 20208.9%
UNITED STATES STL CORP NEW24Q3 202311.4%
NEW YORK TIMES CO23Q3 202310.9%
VANECK VECTORS ETF TR21Q3 202319.5%
PAN AMERN SILVER CORP21Q3 20237.6%
CUE BIOPHARMA INC17Q3 20231.3%
BARRICK GOLD CORPORATION16Q4 202015.7%
MOSAIC CO NEW15Q4 202116.8%
MEDICINES CO15Q4 201912.2%

View Slate Path Capital LP's complete holdings history.

Latest significant ownerships (13-D/G)
Slate Path Capital LP Q4 2015 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Cue Biopharma, Inc.February 14, 20232,402,4555.6%
Stitch Fix, Inc.February 14, 2023? ?
Cyclerion Therapeutics, Inc.January 13, 20237,157,60116.5%
Zimmer Energy Transition Acquisition Corp.February 14, 20222,000,0005.8%
5:01 Acquisition Corp.February 11, 2022500,0005.8%
Hippo Holdings Inc.February 11, 2022350,0000.1%
Warner Music Group Corp.February 11, 20223,134,7792.6%
Reinvent Technology Partners ZFebruary 16, 20211,750,0007.6%

View Slate Path Capital LP's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-02-14
SC 13G/A2024-01-22
13F-HR2023-11-14
13F-HR2023-08-14
13F-HR2023-05-15
SC 13G/A2023-02-14
SC 13G2023-02-14
13F-HR2023-02-14
SC 13G2023-01-13
SC 13G2022-11-18

View Slate Path Capital LP's complete filings history.

Compare quarters

Export Slate Path Capital LP's holdings